TAIPEI, TAIWAN, August 20th 2024 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a a global leader in pharmaceutical manufacturing, today announced that it has completed the acquisition from Emergent BioSolutions (“Emergent”, NYSE: EBS) of its sterile manufacturing facility in Baltimore-Camden, Maryland. The facility adds drug product fill/finish to Bora’s extensive...
《HR Asia》, the leading HR magazine in Asia, recently announced the winners of the 2024 “The HR Asia Best Companies to Work for in Asia Awards.” Bora Pharmaceuticals stood out among nearly 370 participating companies, not only winning the prestigious HR Asia Best Companies to Work for in Asia Taiwan 2024 award for the second time but also receiving the HR Asia Most Caring Company Awards 2024, recognizing its commitment to the “People First” philosophy since its inception as one of the core competences of the Bora Group.
Bora Pharmaceuticals announced it entered into an agreement for Emergent BioSolutions’ sterile manufacturing facility in Baltimore-Camden, Maryland as part of a major commercial expansion for the Company.
The Office of the President Taiwan announced the winners of the 6th “Presidential Innovation” Award, and Bora Pharmaceuticals has been awarded as the winner of the “President Innovation Award for Service Innovation”